Literature DB >> 26828309

Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.

Jason Bugno1, Hao-Jui Hsu1, Ryan M Pearson1, Hyeran Noh2, Seungpyo Hong1,3.   

Abstract

An enormous effort has been put into designing nanoparticles (NPs) with controlled biodistributions, prolonged plasma circulation times, and/or enhanced tissue targeting. However, little is known about how to design NPs with precise distributions in the target tissues. In particular, understanding NP tumor penetration and accumulation characteristics is crucial to maximizing the therapeutic potential of drug molecules carried by the NPs. In this study, we employed poly(amidoamine) (PAMAM) dendrimers, given their well-controlled size (<10 nm) and surface charge, to understand how the physical properties of NPs govern their tumor accumulation and penetration behaviors. We demonstrate for the first time that the size and surface charge of PAMAM dendrimers control their distributions in both a 3D multicellular tumor spheroid (MCTS) model and a separate extracellular matrix (ECM) model, which mimics the tumor microenvironment. Smaller PAMAM dendrimers not only diffused more rapidly in the ECM model but also efficiently penetrated to the MCTS core compared to their larger counterparts. Furthermore, cationic, amine-terminated PAMAM dendrimers exhibited the greatest accumulation in MCTS compared to either charge-neutral or anionic dendrimers. Our findings indicate that the size and surface charge of PAMAM dendrimers may tailor their tumor accumulation and penetration behaviors. These results suggest that controlled tumor accumulation and distinct intratumoral distributions can be achieved by simply controlling the size and surface charge of dendrimers, which may also be applicable for other similarly sized NPs.

Entities:  

Keywords:  PAMAM; multicellular tumor spheroids; nanoparticles; tumor penetration

Mesh:

Substances:

Year:  2016        PMID: 26828309     DOI: 10.1021/acs.molpharmaceut.5b00946

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  18 in total

1.  3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.

Authors:  Simonas Daunys; Agnė Janonienė; Indrė Januškevičienė; Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines.

Authors:  Geoffrey M Lynn; Richard Laga; Christopher M Jewell
Journal:  Cancer Lett       Date:  2019-06-08       Impact factor: 8.679

3.  Conventional Nanosized Drug Delivery Systems for Cancer Applications.

Authors:  Cristian Vergallo; Muhammad Nadeem Hafeez; Dalila Iannotta; Hélder A Santos; Nicola D'Avanzo; Luciana Dini; Felisa Cilurzo; Massimo Fresta; Luisa Di Marzio; Celia Christian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue.

Authors:  Muhammad Usman Munir
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

Review 5.  Branched, dendritic, and hyperbranched polymers in liquid biopsy device design.

Authors:  Michael J Poellmann; Piper Rawding; DaWon Kim; Jiyoon Bu; YoungSoo Kim; Seungpyo Hong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-04

6.  Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.

Authors:  Wen Yang; Hanitrarimalala Veroniaina; Xiaole Qi; Pengyu Chen; Feng Li; Pu Chun Ke
Journal:  Adv Ther (Weinh)       Date:  2019-10-16

7.  Tuning the Selectivity of Dendron Micelles Through Variations of the Poly(ethylene glycol) Corona.

Authors:  Ryan M Pearson; Soumyo Sen; Hao-Jui Hsu; Matt Pasko; Marilyn Gaske; Petr Král; Seungpyo Hong
Journal:  ACS Nano       Date:  2016-07-05       Impact factor: 15.881

Review 8.  Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.

Authors:  Livia Palmerston Mendes; Jiayi Pan; Vladimir P Torchilin
Journal:  Molecules       Date:  2017-08-23       Impact factor: 4.411

Review 9.  From 2D to 3D Cancer Cell Models-The Enigmas of Drug Delivery Research.

Authors:  Indra Van Zundert; Beatrice Fortuni; Susana Rocha
Journal:  Nanomaterials (Basel)       Date:  2020-11-11       Impact factor: 5.076

10.  Recent advances in drug delivery systems for enhancing drug penetration into tumors.

Authors:  Bin He; Xin Sui; Bing Yu; Song Wang; Youqing Shen; Hailin Cong
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.